For any questions or inquiries, please feel free to contact us.
ARENSIA UKRAINE RESUMES PHASE 1 TRIAL IN PATIENTS WITH MULTIPLE SCLEROSIS
Last week, ARENSIA clinic in Ukraine resumed participation in a Phase I trial with an innovative drug targeting Multiple...
HAPPY INTERNATIONAL WOMEN´S DAY
Happy International Women's Day! Today, and every day we celebrate the social, economic, cultural, and political ach...
MEETING WITH DEPUTY SECRETARY GENERAL OF NATO
As part of our strategy to stay connected with the business communities of the countries we are operating in, ARENSIA re...
DR. CLAUDIA HESSELMANN MEETING THE NEW GOVERMENT OF MOLDOVA
On Wednesday, 1st of March, ARENSIA’s Founder & CEO, Dr. Claudia Hesselmann, participated in a meeti...
1 YEAR OF WAR IN UKRAINE
Our entire ARENSIA family is proud of our incredible team in Ukraine, who have continued to work tirelessly during the c...
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS IN KYIV, UKRAINE
ARENSIA clinic in Kyiv started the New Year by administering an innovative drug to patients with paroxysmal nocturnal he...
UKRAINE UPDATE
The last few days saw an increase in hostilities. While condemning the aggression, one needs to put it into perspective ...
LATEST PERFORMANCE AT ARENSIA CLINIC IN KYIV, UKRAINE
12 patients with Ulcerative Colitis in a Phase 2a exploratory trial have been screened in the last three weeks. The firs...
We are thankful to all our partners and friends for a year of succesful collaboration midst a grim pandemic and for the amazing efforts we all put together to advance the science of many new therapies for our patients.
Merry Christmas & HAPPY NEW YEAR!!!
23.12.2021
VIDEO INTRO
